These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7477102)

  • 1. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12.
    Carter R; Coulson A; Bhatti S; Taylor BJ; Elliott JF
    Mol Biochem Parasitol; 1995 May; 71(2):203-10. PubMed ID: 7477102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum.
    Gerloff DL; Creasey A; Maslau S; Carter R
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13598-603. PubMed ID: 16155126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
    Singh K; Burkhardt M; Nakuchima S; Herrera R; Muratova O; Gittis AG; Kelnhofer E; Reiter K; Smelkinson M; Veltri D; Swihart BJ; Shimp R; Nguyen V; Zhang B; MacDonald NJ; Duffy PE; Garboczi DN; Narum DL
    Commun Biol; 2020 Jul; 3(1):395. PubMed ID: 32709983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
    MacDonald NJ; Nguyen V; Shimp R; Reiter K; Herrera R; Burkhardt M; Muratova O; Kumar K; Aebig J; Rausch K; Lambert L; Dawson N; Sattabongkot J; Ambroggio X; Duffy PE; Wu Y; Narum DL
    J Biol Chem; 2016 Sep; 291(38):19913-22. PubMed ID: 27432885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies against Pfs230 block Plasmodium falciparum transmission.
    Dietrich MH; Gabriela M; Reaksudsan K; Dixon MWA; Chan LJ; Adair A; Trickey S; O'Neill MT; Tan LL; Lopaticki S; Healer J; Keremane S; Cowman AF; Tham WH
    Biochem J; 2022 Dec; 479(24):2529-2546. PubMed ID: 36520108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.
    Vincent AA; Fanning S; Caira FC; Williamson KC
    Parasite Immunol; 1999 Nov; 21(11):573-81. PubMed ID: 10583858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M; Miura K; Takashima E; Morita M; Nagaoka H; Zhou L; Long CA; Richter King C; Torii M; Tsuboi T; Ishino T
    Vaccine; 2019 Mar; 37(13):1799-1806. PubMed ID: 30824357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate.
    Lee SM; Wu Y; Hickey JM; Miura K; Whitaker N; Joshi SB; Volkin DB; Richter King C; Plieskatt J
    Malar J; 2019 Nov; 18(1):356. PubMed ID: 31703583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate.
    Williamson KC; Fujioka H; Aikawa M; Kaslow DC
    Mol Biochem Parasitol; 1996 Jun; 78(1-2):161-9. PubMed ID: 8813686
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Singh SK; Thrane S; Chourasia BK; Teelen K; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer MG; Nielsen MA; Salanti A; Sander AF; Sauerwein RW; Jore MM; Theisen M
    Front Immunol; 2019; 10():1256. PubMed ID: 31231386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.
    Riley EM; Williamson KC; Greenwood BM; Kaslow DC
    Parasite Immunol; 1995 Jan; 17(1):11-9. PubMed ID: 7731731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.
    Mistarz UH; Singh SK; Nguyen TTTN; Roeffen W; Yang F; Lissau C; Madsen SM; Vrang A; Tiendrebeogo RW; Kana IH; Sauerwein RW; Theisen M; Rand KD
    Pharm Res; 2017 Sep; 34(9):1970-1983. PubMed ID: 28646324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase.
    Merino KM; Bansal GP; Kumar N
    Immunology; 2016 Aug; 148(4):433-47. PubMed ID: 27177843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.
    Kundu P; Semesi A; Jore MM; Morin MJ; Price VL; Liang A; Li J; Miura K; Sauerwein RW; King CR; Julien JP
    Nat Commun; 2018 Oct; 9(1):4458. PubMed ID: 30367064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate.
    Lee SM; Plieskatt J; Krishnan S; Raina M; Harishchandra R; King CR
    Protein Expr Purif; 2019 Aug; 160():56-65. PubMed ID: 30978392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana.
    Acquah FK; Obboh EK; Asare K; Boampong JN; Nuvor SV; Singh SK; Theisen M; Williamson KC; Amoah LE
    Malar J; 2017 Aug; 16(1):306. PubMed ID: 28764709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes.
    Williamson KC; Keister DB; Muratova O; Kaslow DC
    Mol Biochem Parasitol; 1995 Dec; 75(1):33-42. PubMed ID: 8720173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
    Healer J; McGuinness D; Carter R; Riley E
    Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
    Ivanochko D; Fabra-García A; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Newton J; Semesi A; de Bruijni M; Bolscher J; Ramjith J; Szabat M; Vogt S; Kraft L; Duncan S; Lee SM; Kamya MR; Feeney ME; Jagannathan P; Greenhouse B; Sauerwein RW; Richter King C; MacGill RS; Bousema T; Jore MM; Julien JP
    Immunity; 2023 Feb; 56(2):420-432.e7. PubMed ID: 36792575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production.
    Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
    Mol Microbiol; 2006 Aug; 61(4):991-8. PubMed ID: 16879650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.